- This event has passed.
3rd Annual Epigenetics Discovery Congress in London, UK
October 12 - October 13
After our two successful editions, we are glad to announce the 3rd Annual Epigenetics Discovery Congress.
With a tremendous progress in technology to generate and analyze reference epigenomes, the epigenetics field is fetching a lot of importance and attention across all medical science’s areas. Additionally, novel epigenetic molecules across many target classes for drug discovery, have been the prime focus of the pharmaceutical industry.
To meet and support this pace of the epigenetics research and development field, the 3rd Annual Epigenetics Discovery Congress will present novel research and address challenges right from molecular sciences & disease diagnosis to drug discovery streams. The congress will also be a great platform to learn about novel technologies like next generation sequencing and single cell analysis.
Paola Arimondo, ETaC, France
Roland Baumgartner, 4SC, Germany
Carlos Buesa, Oryzon, Spain
Susan Clark, Garvan Institute of Medical Research, Sydney, Australia
Jerome Dejardin, MSH, France
James Flanagan, Imperial College London, UK
Petra Hajkova, MRC Institute of Medical Sciences (LMS), UK
John Holloway, University of Southampton, UK
Kilian Huber, University of Oxford, UK
Paul Hurd, Queen Mary University of London, UK
Karen Lillycrop, University of Southampton, UK
Gavin Kelsey, The Babraham Institute, UK
Guro Lind, University of Oslo, Norway
Jelena Mann, Newcastle University, UK
Rab Prinjha, GlaxoSmithKline, UK
Joëlle Rüegg, Karolinska Institutet, Sweden
Christopher Schofield, University of Oxford, UK
Paul Shiels, University of Glasgow, UK
Jesse Smith, Epizyme, USA
Rémi Terranova, Novartis Institutes for BioMedical Research, Switzerland
Maria Toledo, University of Nottingham, United Kingdom
Jonathan Turner, Luxembourg Institute of Health, Luxembourg
Katherine West, University of Glasgow, UK
David M. Wilson, Astrazeneca, UK